Subsequent female breast cancer risk associated with anthracycline chemotherapy for childhood cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Subsequent female breast cancer risk associated with anthracycline chemotherapy for childhood cancer ; volume:29 ; number:9 ; day:11 ; month:9 ; year:2023 ; pages:2268-2277 ; date:9.2023
Nature medicine ; 29, Heft 9 (11.9.2023), 2268-2277, 9.2023
- Creator
-
Wang, Yuehan
Ronckers, Cécile M.
Leeuwen, Flora E. van
Moskowitz, Chaya S.
Leisenring, Wendy
Armstrong, Gregory T.
Vathaire, Florent de
Hudson, Melissa M.
Kuehni, Claudia E.
Arnold, Michael A.
Demoor-Goldschmidt, Charlotte
Green, Daniel M.
Henderson, Tara O.
Howell, Rebecca M.
Ehrhardt, Matthew J.
Neglia, Joseph P.
Oeffinger, Kevin C.
Pal, Helena J. H. van der
Robison, Leslie L.
Schaapveld, Michael
Turcotte, Lucie M.
Waespe, Nicolas
Kremer, Leontien C. M.
Teepen, Jop C.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41591-023-02514-1
- URN
-
urn:nbn:de:101:1-2023112913320499479561
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Yuehan
- Ronckers, Cécile M.
- Leeuwen, Flora E. van
- Moskowitz, Chaya S.
- Leisenring, Wendy
- Armstrong, Gregory T.
- Vathaire, Florent de
- Hudson, Melissa M.
- Kuehni, Claudia E.
- Arnold, Michael A.
- Demoor-Goldschmidt, Charlotte
- Green, Daniel M.
- Henderson, Tara O.
- Howell, Rebecca M.
- Ehrhardt, Matthew J.
- Neglia, Joseph P.
- Oeffinger, Kevin C.
- Pal, Helena J. H. van der
- Robison, Leslie L.
- Schaapveld, Michael
- Turcotte, Lucie M.
- Waespe, Nicolas
- Kremer, Leontien C. M.
- Teepen, Jop C.
- SpringerLink (Online service)
Other Objects (12)
Anthracycline Chemotherapy and Cardiotoxicity
Degree of diffuse fibrosis measured by MRI correlates with LV remodelling in childhood cancer survivors after anthracycline chemotherapy
Right heart function deteriorates in breast cancer patients undergoing anthracycline-based chemotherapy
Novel Anthracycline Utorubicin for Cancer Therapy
Novel Anthracycline Utorubicin for Cancer Therapy
Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer
Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy
PITX2 DNA methylation predicts response to anthracycline-based chemotherapy in triple negative breast cancer
FKBP12 is a predictive biomarker for efficacy of anthracycline-based chemotherapy in breast cancer
Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer
Role of baseline echocardiography prior to initiation of anthracycline-based chemotherapy in breast cancer patients
NUP98 – a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancer
Anthracycline Chemotherapy and Cardiotoxicity
Degree of diffuse fibrosis measured by MRI correlates with LV remodelling in childhood cancer survivors after anthracycline chemotherapy
Right heart function deteriorates in breast cancer patients undergoing anthracycline-based chemotherapy
Novel Anthracycline Utorubicin for Cancer Therapy
Novel Anthracycline Utorubicin for Cancer Therapy
Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer
Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy
PITX2 DNA methylation predicts response to anthracycline-based chemotherapy in triple negative breast cancer
FKBP12 is a predictive biomarker for efficacy of anthracycline-based chemotherapy in breast cancer
Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer
Role of baseline echocardiography prior to initiation of anthracycline-based chemotherapy in breast cancer patients
NUP98 – a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancer
Anthracycline Chemotherapy and Cardiotoxicity
Degree of diffuse fibrosis measured by MRI correlates with LV remodelling in childhood cancer survivors after anthracycline chemotherapy
Right heart function deteriorates in breast cancer patients undergoing anthracycline-based chemotherapy
Novel Anthracycline Utorubicin for Cancer Therapy
Novel Anthracycline Utorubicin for Cancer Therapy
Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer
Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy
PITX2 DNA methylation predicts response to anthracycline-based chemotherapy in triple negative breast cancer
FKBP12 is a predictive biomarker for efficacy of anthracycline-based chemotherapy in breast cancer
Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer
Role of baseline echocardiography prior to initiation of anthracycline-based chemotherapy in breast cancer patients